medigraphic.com
ISSN 1405-1710 (Print)

2008, Number 3

Next >>

Rev Cent Dermatol Pascua 2008; 17 (3)

Efficacy and tolerability of polidocanol 1% in the treatment with sclerotherapy of varices degree I and II, with compressive technique in the proximal third affected

Llergo VRJ, Enríquez MJ

Language: Spanish
References: 32
Page: 79-83
PDF size: 132.76 Kb.


ABSTRACT

Objective: To compare the efficacy and tolerability of polidocanol 1% in the treatment of varices degree I and II with compressive technique in the proximal third affected and technique without compression. Patients and methods: This is a prospective, randomized, longitudinal and comparative study of selected cases. We studied a total of 248 female patients with varices degree I and II who arrived for first time or subsequent to extern consult of Centro Dermatológico “Dr. Ladislao de la Pascua” from August 2007 to May 2008. We performed sclerotherapy with compression in the proximal third affected in 124 cases and without compression in the other half of patients. Results: We observe improvement of 100% after first session of sclerotherapy in 44% of poblation with technique of compression, compared with 23% of patients without compressive technique. The rest of patients of booth groups need other sessions. Conclusions: We observed no difference into 45 days after sclerotherapy with polidocanol 1%, between the technique with compression and without one.


REFERENCES

  1. Murad A. Tratamiento de las várices. Elsevier, 2007: 1-106.

  2. Christoph J. The History of Sclerosing foams. Dermatol Surg 2004; 30: 694-703.

  3. Rabe E. Guidelines for sclerotherapy of varicose veins. Dermatol Surg 2004; 30: 688-93.

  4. Breu F. European consensus meeting on foam sclerotherapy. Dermatol Surg 2004; 30: 709-17.

  5. Juárez-Arce V, Hernández-Pérez E. Escleroterapia: revisión del tema. Dermatología Rev Mex 1998; 42: 77-82.

  6. Goldman M, Bennet R. Treatment of telangiectasia: A review. J Am Acad Dermatol 1987; 17: 167-82.

  7. Weiss R, Weiss M. Sclerotherapy for varicose and telangiectatic veins. In: Dermatology in General Medicine. 5th ed. Mc Graw-Hill, 1999: 2959-67.

  8. Gardner E. Venas y linfáticos del miembro inferior. En: Anatomía, estudio por regiones del cuerpo humano. 6ª edición. Editorial Salvat. 1992: 232-8.

  9. Moore K. Irrigación de la extremidad inferior. En: Anatomía con orientación clínica. 3ª edición. Editorial médica panamericana 1994; 398-404.

  10. Goldman M, Weiss R, Bergan J. Diagnosis and treatment of varicose veins: A review. J Am Acad Dermatol 1994; 31: 393-413.

  11. Somjen G. Anatomy of the superficial venous system. Dermatol Surg 1995; 21: 35-45.

  12. Tretbar I. Deep Veins. Dermatol Surg 1995; 21: 47-51.

  13. Sadick N. Predisposing factors of varicose and telangiectatic leg veins. J Dermatol Surg Oncol 1992; 18: 883-886.

  14. Folkman J, Klagsburn M. Angiogenic factors. Science 1987; 235: 442-7.

  15. Vin F, Allaert FA, Levardon M. Influence of estrogens and progesterone on the venous system of the lower limbs in woman. J Dermatol Surg Oncol 1992; 18: 888-892.

  16. Weiss R. Sclerotherapy of varicose veins of the lower limbs. Dermatol Surg 1996; 22: 883-9.

  17. Weiss R, Goldman M. Advances in 17. Sclerotherapy. Dermatologic Clinics 1995; 13: 431-45.

  18. Butie A. Clinical examination of varicose veins. Dermatol Surg 1995; 21: 52-6.

  19. Kenneth P, Lewix W. Recurrent varicose veins. J Dermatol Surg Oncol 1992; 18: 895-900.

  20. Norris M, Carlin M, Louis Ratz J. Treatment of essential telangiectasia: Effects of increasing concentrations of polidocanol. J Am Acad Dermatol 1989; 20: 643-9.

  21. Sadick N, Senterfit L, Klein R. The intrinsic antimicrobial activity of selected sclerosing agents in sclerotherapy. Dermatol Surg 1996; 22: 369-71.

  22. Feled C, Jackson J, Bren T et al. Allergic reactions to polidocanol for vein sclerosis. J Dermatol Surg Oncol 1994; 20: 466-8.

  23. Weiss R. Polidocanol: the perfect solution. J Dermatol Surg Oncol 1994; 20: 465.

  24. Martin D, Goldman. A comparison of sclerosing agents: clinical and histologic effects of intravascular sodium tetradecyl sulfate and chromated glycerin in the dorsal rabbit ear vein. J Dermatol Surg Oncol 1990; 16: 18-22.

  25. Gallagher P, Faca F. Varicose veins, primary treatment with sclerotherapy. J Dermatol Surg Oncol 1992; 18: 39-42.

  26. Ocampo-Candiani J, Villareal-Rodríguez A, González-Madrazo R. Escleroterapia. Dermatología Rev Mex 1990; 34: 341-6.

  27. Moreno-González L. Escleroterapia. Dermatología Rev Mex 1991; 35: 245.

  28. Goldman M, Beaudoing D, López et al. Compression in the treatment of leg telangiectasia: a preliminary report. J Dermatol Surg Oncol 1990; 16: 322-5.

  29. García C, Poletti E, Jiménez A et al. Controversias en escleroterapia. Dermatología Rev Mex 1997; 41:239-242.

  30. Thiers B. Sclerotherapy treatment insights. Dermatologic Clinics 1998; 19: 641-646.

  31. Zimmet S. The prevention of cutaneous necrosis following extravasation of hypertonic saline and sodium tetradecyl sulfate. J Dermatol Surg Oncol 1993; 19:641-646.

  32. Zimmet S. Hyaluronidase in the prevention of sclerotherapy-induced extravasation necrosis. Dermatol Surg 1996; 22: 73-76.




2020     |     www.medigraphic.com